Kazuyuki Shimada Selected Research

Kazuyuki Shimada Research Topics

Disease

57	Hypertension (High Blood Pressure) 01/2020 - 01/2002
30	Stroke (Strokes) 01/2020 - 01/2002
27	Neoplasms (Cancer) 10/2023 - 04/2003
23	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 10/2002
20	Coronary Artery Disease (Coronary Atherosclerosis) 07/2012 - 03/2002
18	Lymphoma (Lymphomas) 12/2021 - 02/2004
17	Myocardial Infarction 01/2019 - 01/2002
14	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 02/2004
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 04/2008
12	Atherosclerosis 01/2012 - 03/2002
11	Inflammation (Inflammations) 07/2012 - 03/2002
10	Diabetes Mellitus 04/2018 - 04/2007
8	Chronic Renal Insufficiency 01/2023 - 04/2007
8	Heart Failure 09/2022 - 05/2003
8	Essential Hypertension 05/2015 - 05/2002
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2022 - 10/2004
6	Hemorrhage 02/2020 - 03/2006
6	Hypoxia (Hypoxemia) 02/2017 - 11/2005
6	Obesity 06/2012 - 07/2007
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2011 - 07/2002
6	Cerebral Infarction 11/2011 - 10/2003
5	Disease Progression 05/2024 - 10/2005
5	Isolated Systolic Hypertension 01/2017 - 09/2004
5	Ischemic Stroke 01/2016 - 02/2004
5	Masked Hypertension 03/2015 - 04/2007
5	Cardiomegaly (Heart Hypertrophy) 06/2012 - 12/2002
5	Hypercholesterolemia 01/2012 - 10/2004
5	Atherosclerotic Plaque (Atheroma) 10/2004 - 03/2002
4	Dyslipidemias (Dyslipidemia) 01/2019 - 03/2010
4	Sleep Apnea Syndromes (Sleep Apnea) 10/2012 - 09/2006
4	Unstable Angina 01/2011 - 04/2002
4	Pulmonary Arterial Hypertension 09/2007 - 10/2006
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2024 - 05/2009
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021 - 01/2019
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 09/2012
3	White Coat Hypertension 03/2015 - 04/2007
3	Ulcer 05/2014 - 10/2005
3	Type 2 Diabetes Mellitus (MODY) 03/2013 - 04/2004
3	Apnea 10/2012 - 09/2006
3	Acute Coronary Syndrome 10/2012 - 01/2012
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2012 - 03/2007
3	Cognitive Dysfunction 06/2012 - 07/2008
3	Insulin Resistance 04/2011 - 01/2007

Drug/Important Bio-Agent (IBA)

26	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 01/2002
18	Rituximab (Mabthera)FDA Link 05/2024 - 02/2004
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2020 - 06/2008
12	Angiotensin Receptor AntagonistsIBA 01/2018 - 05/2003
11	olmesartanIBA 10/2018 - 04/2011
10	DiureticsIBA 10/2015 - 01/2002
10	Losartan (Cozaar)FDA LinkGeneric 05/2015 - 04/2004
9	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 05/2002
9	Proteins (Proteins, Gene)FDA Link 12/2017 - 12/2004
9	Angiotensin IIIBA 08/2012 - 10/2002
9	C-Reactive ProteinIBA 11/2011 - 10/2002
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2012 - 03/2002
8	LipidsIBA 01/2012 - 03/2002
7	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2007
7	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 08/2003
7	Glucose (Dextrose)FDA LinkGeneric 02/2017 - 01/2007
7	azelnidipineIBA 03/2013 - 06/2007
7	CholesterolIBA 07/2008 - 07/2002
6	LigandsIBA 12/2021 - 01/2004
6	benidipineIBA 01/2020 - 08/2011
6	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2018 - 04/2005
6	Amlodipine (Norvasc)FDA LinkGeneric 05/2015 - 05/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012 - 03/2002
6	Eicosapentaenoic AcidIBA 01/2012 - 07/2008
5	Oxygen (Dioxygen)IBA 01/2021 - 08/2002
5	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 05/2015 - 04/2011
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2011 - 01/2002
4	1,4-dihydropyridine (dihydropyridine)IBA 01/2018 - 12/2009
4	Histones (Histone)IBA 12/2017 - 12/2004
4	Valsartan (Vals)FDA Link 01/2017 - 09/2004
4	antineoplaston A10 (A 10)IBA 02/2014 - 12/2003
4	CalciumIBA 11/2013 - 05/2002
4	Doxazosin (Cardura)FDA LinkGeneric 01/2013 - 08/2004
4	oxidized low density lipoproteinIBA 01/2012 - 04/2002
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2006 - 04/2002
3	Vincristine (Oncovin)FDA LinkGeneric 05/2024 - 01/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2003
3	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 01/2019
3	AntibodiesIBA 01/2021 - 01/2019
3	Prednisolone (Predate)FDA LinkGeneric 12/2020 - 01/2015
3	ThiazidesIBA 01/2020 - 04/2012
3	CreatinineIBA 11/2018 - 08/2010
3	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 04/2018 - 12/2014
3	GhrelinIBA 05/2014 - 01/2010
3	Hemostatics (Antihemorrhagics)IBA 04/2013 - 07/2005
3	AlbuminsIBA 03/2013 - 06/2008
3	Olmesartan Medoxomil (Votum)FDA Link 05/2012 - 12/2009
3	Monoclonal AntibodiesIBA 04/2011 - 09/2009
3	Insulin (Novolin)FDA Link 06/2010 - 06/2006
3	Adrenergic Agents (Adrenergic Drugs)IBA 06/2009 - 07/2002

Therapy/Procedure

45	Therapeutics 01/2024 - 09/2002
14	Drug Therapy (Chemotherapy) 11/2023 - 04/2008
3	Aftercare (After-Treatment) 01/2019 - 05/2002
3	Denervation 01/2019 - 01/2015
3	Secondary Prevention 06/2011 - 03/2007